Lipidor
0.188
SEK
+3.87 %
LIPI
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 following
+3.87%
+60.68%
+42.42%
+31.01%
+42.19%
+58.54%
-91.42%
-94.14%
-89.37%
Lipidor is a pharmaceutical company. The company works with research and development in the preclinical and clinical phases. The largest business is established in the development of pharmaceuticals that are further used for the treatment of various skin diseases. Examples of diseases that are treated include psoriasis, various skin infections, and atopic dermatitis. The head office is located in Solna.
Read moreMarket cap
152.92M SEK
Turnover
842.11K SEK
Revenue
80K
EBIT %
-19,312.5 %
P/E
-
Dividend yield-%
-
Financial calendar
28.2
2025
Annual report '24
3.6
2025
General meeting '24
28.8
2025
Interim report Q2'25
ShowingAll content types
Lipidor publishes CEO statement for the quarter: "Study results expected by the end of Q1 2025"
Lipidor announces first patient enrolled in Phase III study of AKP02G2 for topical treatment of psoriasis
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools